0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Combination Treatment in Autoimmune Diseases (Hardcover, 2002 ed.) Loot Price: R3,223
Discovery Miles 32 230
You Save: R1,263 (28%)
Combination Treatment in Autoimmune Diseases (Hardcover, 2002 ed.): W.B. Harrison, B.A.C. Dijkmans

Combination Treatment in Autoimmune Diseases (Hardcover, 2002 ed.)

W.B. Harrison, B.A.C. Dijkmans

 (sign in to rate)
List price R4,486 Loot Price R3,223 Discovery Miles 32 230 | Repayment Terms: R302 pm x 12* You Save R1,263 (28%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Donate to Against Period Poverty

W. B. Harrison, B. A. C. Dijkmans During the last decade intervention has been instituted for all kinds of disease- even in a premorbid state, as early as possible, to control the activity of the disease, to avoid further damage and to maintain quality of life. Apart from the principle 'Treat now, not later," emphasis is laid on aggressive initial therapy. These adagia have influenced in recent times all fields of medicine, from oncology to infectious diseases and also - the topic of the present edition - the "autoimmune diseases." As an example of the latter, rheumatoid arthritis (RA) demonstrates how the attitude of physicians has been changed. From an expectant point of view in the eighties (primum nil nocere) the attitude has been changed, as we approached and entered the new millennium, to initial ag gressive therapy especially in patients with a poor prognosis. Despite the advance of instituting monotherapy with a single optimised disease-modifying anti-rheumatic drug (DMARD) - with methotrexate as prototype agent in RA - adequate disease re mission is not often achieved, and adverse events may well prevent the use of higher dosages of the single agent in question. Therefore, the next step was to combine two or more DMARDs. The choice of combining DMARDs can be purely practical and based upon the anti-rheumatics most used in daily practice, for instance methotrexate and sulphasalazine. The choice of combining drugs can be influenced by different toxicity patterns to avoid cumulative toxicity."

General

Imprint: Springer-Verlag
Country of origin: Germany
Release date: February 2002
First published: 2002
Editors: W.B. Harrison • B.A.C. Dijkmans
Dimensions: 235 x 155 x 14mm (L x W x T)
Format: Hardcover
Pages: 213
Edition: 2002 ed.
ISBN-13: 978-3-540-43036-0
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 3-540-43036-9
Barcode: 9783540430360

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners